Health Trials

About this trial

BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices.

This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.

Eligibility criteria

Qualifiers

Provision of a signed, written and dated informed consent or non-opposition (where applicable)

Disqualifiers

Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)

Contra-indications of each device as described in the instructions for use.

Trial design

Treatments tested in this trial

  • BALT medical devices

Treatment groups

10,000 Participants
are divided into 1 treatment group

Locations

12
France
CHU Angers Angers France
Chu Bordeaux Bordeaux France
CHU Grenoble Alpes La Tronche France
Hôpital Roger Salengro Lille France

Sponsors and collaborators

Balt Extrusion

Lead sponsor

Source ClinicalTrials.gov